National
Eyes on N.H. for GOP presidential primary
Romney enjoys strong lead, but Santorum rising
[Editor’s Note: The Washington Blade will have this reporter in New Hampshire next week for the New Hampshire primary.]
Eyes are turning to New Hampshire as the next battleground state for Republican candidates seeking the White House.
The GOP contenders are set to compete Tuesday in a primary to determine who’ll win the state’s 12 at-large delegates in the race to win the Republican nomination.
Former Massachusetts Gov. Mitt Romney, coming off a narrow win of eight votes in the Iowa caucuses earlier this week, is the strong front-runner in the polls for a second win in New Hampshire.
According to a Suffolk University/7News Poll published on Friday, Romney holds a strong lead of 40 percent from likely Republican primary voters in the Granite State. He’s followed by libertarian Rep. Ron Paul (R-Texas), who has support from 17 percent of poll responders.
Jimmy LaSalvia, executive director of the gay conservative group GOProud, predicted that Romney would be victorious on Tuesday and the win would make certain he would be the Republican presidential nominee.
“No non-incumbent Republican candidate has ever won both Iowa and New Hampshire,” LaSalvia said via email. “If Romney does this, it would be unprecedented. He’s leading in all of the national and state polls, so if he wins New Hampshire the race for the nomination is over. AND he will win New Hampshire.”
LaSalvia endorsed Romney in op-ed piece published in Friday in the Daily Caller, citing economic and tax policy as reasons to support the candidate. The endorsement was a personal one, and not on behalf on GOProud.
Romney has a reputation for being less anti-gay than other candidates for saying he favors gay rights. Unlike other candidates, he said wouldn’t restore “Don’t Ask, Don’t Tell” and is against discrimination based on sexual orientation. Still, he opposes same-sex marriage and backs the Federal Marriage Amendment.
While Romney and Paul are ahead in New Hampshire, former U.S. Sen. Rick Santorum has risen in the polls in the state following his strong second-place showing in the Iowa caucuses. In the Suffolk University/7News Poll, the candidate has vaulted into third place in New Hampshire by claiming 11 percent of support.
David Paleologos, director of the Suffolk University Political Research Center, said the poll shows momentum for Santorum.
“Rick Santorum is the only Republican candidate moving up in New Hampshire,” Paleologos said. “He has cleared the [former U.S. House Speaker Newt] Gingrich and [former Utah Gov. Jon] Huntsman hurdles for third place and is only 6 points away from second place. Watch out Ron Paul.”
But Santorum has been enjoying a less than popular reception from some of the attendees during crowds at his campaign events in the state over his opposition to gay rights.
In one such instance on Friday during a town hall in Keene, N.H., Santorum reiterated his opposition to same-sex marriage and his belief that gays shouldn’t be able to serve openly in the military.
“Everybody has certain inalienable rights, serving in the military is not an alienable right,” Santorum said. “It’s a privilege. You’re selected. Not everybody can serve for a variety of different reasons.”
Explaining his opposition to same-sex marriage, Santorum said, “Marriage is a privilege. It is not a right. It is privilege given by society, held up by society, for purposes that it provides some societal good, and I would make the argument, some extraordinary societal good.”
Santorum continued that if marriage was an inalienable right, one “could imagine all the different types of marriages that would happen.” He added, “It’s not discrimination not to grant privileges, it’s discrimination to deny rights.”
“Everyone has a right to live their life,” Santorum concluded. “That doesn’t mean they’re entitled to live their life. That doesn’t mean that they’re entitled to certain privileges that society gives for certain benefits the society obtains from those relationships.”
Santorum’s remarks are consistent with his support for a Federal Marriage Amendment and his plan to restore “Don’t Ask, Don’t Tell.” Following Santorum’s remarks, several members of the audience responded with boos.
Joe Solmonese, president of the Human Rights Campaign, blasted Santorum for espousing anti-gay views in a state that is known for its libertarian leanings.
“Rick Santorum’s anti-gay hate is not going to perform well in New Hampshire,” Solmonese said. “His reception there is indicative of just how poorly he will fare with mainstream voters as the primaries progress.”
Solmonese continued that Santorum’s position are not just inconsistent with the views of the majority of people in New Hampshire, but also most Americans.
“Rick Santorum’s views are out of step with the majority of Americans across demographics and faiths,” Solmonese said. “He is basing his campaign off of bashing an entire community of his fellow Americans. That may serve him well with certain constituencies, but it’s something most Americans will not stand for.”
Despite Santorum’s rise, Paul remains the candidate in second-place. Although he enjoys a following among libertarians and younger voters — as well as some LGBT people — his views on gays and AIDS have recently come under scrutiny.
In his 1987 book, “Freedom Under Siege,” Paul wrote that a victim of AIDS is “frequently a victim of his own lifestyle.”
On Jan. 1, Paul defended this position during an interview when FOX News’ Chris Wallace asked the candidate if he still holds these views. The candidate suggested the U.S. government shouldn’t fund AIDS treatment efforts.
“Sexually transmitted diseases are caused by sexual activity, and when it’s promiscuous its spreads diseases,” Paul said. “So if a fault comes with people because of their personal behavior — and in a free society, people do dumb things — but [it] isn’t to be placed as a burden on other people, innocent people. Why should they have to pay for the consequences? That’s a sort of a nationalistic, or socialistic, attitude.”
Asked whether people with AIDS should be denied health care coverage, Paul said no, but added that insurance companies and markets should determine the best way to handle such cases.
Carl Schmid, deputy executive director of the AIDS Institute, said Paul’s remarks demonstrate he’s “way outside the thinking of any compassionate rationale human being” and “irrational” because only 13 percent of AIDS patients receive care from private insurance companies — the rest is government subsidized care.
“Congressman Paul does not seem to understand the preventive benefits of people with HIV being in care and treatment,” Schmid said. “When people are not in care the virus will spread even more. If we followed his irresponsible remarks the HIV situation would actually be worse.”
Yet another candidate that many will be watching in New Hampshire is former Utah Gov. Jon Huntsman, Jr. Many observers say a strong showing for Huntsman in New Hampshire, where he has been focusing his campaign, will make or break his path going forward.
But according to the data from University/7News Poll, Huntsman is polling at bottom of the pack. He had support from 8 percent of respondents, although that’s greater than his standing on a national scale.
Huntsman has a strong following among gay Republicans. The candidate supports civil unions and has advocated for a general notion of moving toward equality. Still, said he thinks the anti-gay Defense of Marriage Act “serves a useful purpose.”
R. Clarke Cooper, executive director of the National Log Cabin Republicans, is among those saying Huntsman’s showing in New Hampshire will determine his later moves.
“By foregoing Iowa, Jon Huntsman heavily committed to the ground game in New Hampshire to produce significant voter support,” Cooper said. “How well he performs there will help determine next steps in South Carolina and Florida.”
Cooper has been selected by the Huntsman campaign to represent the candidate as a delegate during the Republican National Convention. Log Cabin hasn’t made an endorsement in the presidential race.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
The White House
EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine
Trans former assistant health secretary’s name changed on official portrait
Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.
The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.
Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.
According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.
Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.
“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.
“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”
“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”
The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.
The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.
The Washington Blade reached out to HHS, but has not received any comment.
The lawsuit and four FOIA requests are below:
A Wider Bridge to close
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
Rehoboth’s Blue Moon is for sale but owners aim to keep it in gay-friendly hands
Comings & Goings
Advocates say MTG bill threatens trans youth, families, and doctors
LGBTQ Democrats say they’re ready to fight to win in 2026
Brian Footer suspends campaign for Ward 1 D.C. Council seat
Far-right José Antonio Kast elected Chile’s next president
Lighting candles in a time of exhaustion
In real estate, trust the process
-
Politics2 days agoLGBTQ Democrats say they’re ready to fight to win in 2026
-
District of Columbia2 days ago
Brian Footer suspends campaign for Ward 1 D.C. Council seat
-
Chile5 days ago
Far-right José Antonio Kast elected Chile’s next president
-
Opinions3 days ago
Lighting candles in a time of exhaustion
